|
시장보고서
상품코드
1983192
일렉트로포레이션 기기 시장 : 제품 유형별, 용도별, 방식별, 최종사용자별, 지역별Electroporation Instruments Market, By Product Type, By Application, By Mode, By End user, By Geography |
||||||
일렉트로포레이션 기기 시장은 2026년에 17억 달러로 추계되고 있으며, 2033년까지 42억 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 9.2%로 성장할 것으로 전망되고 있습니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준연도 | 2025년 | 시장 규모(2026년) | 17억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간의 CAGR(2026-2032년) | 9.20% | 예측 금액(2033년) | 42억 달러 |
일렉트로포레이션(전기천공법)은 박테리아나 효모의 비화학적 형질전환 및 조직배양 세포(예: 포유류 세포)에 대한 형질전환을 가능하게 하는 유용한 분자생물학적 기법입니다. 일렉트로포레이션 시스템은 세포에 고강도의 전기장을 단시간의 펄스로 세포에 인가합니다. 이 전기장에 의해 세포막의 투과성이 높아집니다. 그 결과, 약물이나 유전물질 등의 화학물질이 원래는 투과하지 않아야 할 세포막을 통과할 수 있게 됩니다. 일렉트로포레이션은 그 사용 편의성과 효과로 인해 표적 세포에 외래 유전자를 도입하기 위한 일반적인 방법이 되었습니다. 직접 유전자 도입 외에도, 일렉트로포레이션은 세포 간 또는 종 간(예: 박테리아에서 효모로) 플라스미드의 직접적인 이동을 가능하게 합니다. 생체내 세포에 의약품이나 백신을 직접 전달하기 위한 일렉트로포레이션의 활용은 현재도 광범위하게 연구되고 있습니다. 일렉트로포레이션 시스템은 백신 전달, 유전자 전달 또는 전기화학요법(예: 브레오마이신)과 같은 약물전달을 통한 암 치료에 일반적으로 사용되고 있습니다. 또한 백신 전달은 인간면역결핍바이러스(HIV)와 같은 감염성 질환의 치료에도 활용될 수 있습니다.
시장 역학
세계 일렉트로포레이션 기기 시장에서 활동하는 주요 기업은 브랜드 리뉴얼 및 제휴와 같은 성장 전략에 초점을 맞추고 있으며, 이는 예측 기간 중 시장 성장을 촉진할 것으로 예측됩니다. 예를 들어 이 회사는 즉시 효력을 발휘하여 Eppendorf SE라는 이름으로 사업을 운영하고 있습니다. Eppendorf AG는 2021년 10월 19일자로 Eppendorf SE라는 이름의 유럽 회사(Societas Europaea, SE)로 재편되었습니다. 이번 SE로의 법인 형태 변경은 파트너사와의 기존 비즈니스 관계에 영향을 미치지 않으며, 특히 기존 계약 관계는 변경 없이 계속 유지됩니다. 또한 2022년 7월 15일, MaxCyte, Inc.는 세계 다각화 화학 기업인 LG Chem Ltd.와 전략적 플랫폼 라이선스(SPL)를 체결했다고 발표했습니다. 본 계약 조건에 따라 LG화학은 MaxCyte의 플로우 일렉트로포레이션 기술 및 Expert 플랫폼을 사용할 수 있는 비독점적 임상 및 상업적 권리를 취득합니다. 그 대가로 MaxCyte는 플랫폼 사용료 및 프로그램 관련 매출을 받을 권리가 있습니다.
이 보고서의 주요 특징
- 세계의 일렉트로포레이션 기기 시장에 대해 조사 분석했으며, 예측 기간(2026-2033년) 시장 규모와 CAGR에 대해 조사 분석하여 전해드립니다.
- 또한 각 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요 인사이트을 제공합니다.
- 이 보고서는 세계 일렉트로포레이션 기기 시장의 주요 기업 개요을 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등의 매개 변수를 기반으로 작성되었습니다.
- 이 보고서의 인사이트을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- "세계 일렉트로포레이션 기기 시장" 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 일렉트로포레이션 기기 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 일렉트로포레이션 기기 시장 : 제품 유형별(2026-2033년)
제5장 세계의 일렉트로포레이션 기기 시장 : 용도별(2026-2033년)
제6장 세계의 일렉트로포레이션 기기 시장 : 방식별(2026-2033년)
제7장 세계의 일렉트로포레이션 기기 시장 : 최종사용자별(2026-2033년)
제8장 지역별 세계 일렉트로포레이션 기기 시장(2026-2033년)
제9장 기업 개요
제10장 섹션
KSAElectroporation Instruments Market is estimated to be valued at USD 1.7 Bn in 2026 and is expected to reach USD 4.2 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.7 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.20% | 2033 Value Projection: | USD 4.2 Bn |
Electroporation is a useful molecular biology technique that allows for non-chemical transformation of bacteria and yeasts as well as transfection of tissue culture cells (e.g. mammalian cells). Electroporation systems deliver short bursts of a high-intensity electric field to cells. The electrical field makes the cell membrane more permeable. As a result, chemicals such as drugs and genetic material can pass through the cell membrane, which would otherwise be impermeable. Due to its ease of use and efficacy, electroporation is a popular method for introducing foreign genes into target cells. In addition to direct gene introduction, electroporation allows for the direct transfer of plasmids between cells or species-for instance, from bacteria to yeast. Extensive research is ongoing on the use of electroporation to deliver medicines and vaccines directly to the cells of living organisms. Electroporation systems are commonly used for the treatment of cancer through vaccine delivery, gene delivery or drug delivery that is electrochemotherapy, for instance bleomycin Vaccine delivery can also be used for treatment of infectious disease such as Human immunodeficiency virus (HIV).
Market Dynamics
Key players operating in the global electroporation instruments market are focusing on growth strategies such as rebranding and agreements which is expected to drive the market growth during the forecast period. For instance, The Company is now operating as Eppendorf SE with immediate effect. Eppendorf AG was restructured into a European Company (Societas Europaea, SE) under the name Eppendorf SE, effective October 19, 2021. This change of legal form to an SE does not affect any existing business relationships with their partners; existing contractual relationships in particular continue unchanged. Moreover, On July 15, 2022, MaxCyte, Inc. had announced the Strategic Platform License (SPL) signed with LG Chem Ltd., a global diversified chemical company .Under the terms of the agreement, LG Chem will receive non-exclusive clinical and commercial rights to use MaxCyte's Flow Electroporation technology and ExPERT platform. In return, MaxCyte is entitled to platform license fees and program-related revenues.
Key features of the study
- This report provides in-depth analysis of the global electroporation instruments market, and provides market size (USD Bn) and compound annual growth rate (CAGR) (%) for the forecast period (2026 - 2033).
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by the leading players.
- The report has been prepared after extensive primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global electroporation instruments market.
- The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global electroporation instruments market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global electroporation instruments market.
Market Segmentation
- By Product Type
- Systems
- Accessories
- Electrodes
- Cuvettes
- Chambers
- Kits
- Others
- By Application
- Protein Production
- Drug Delivery
- Biomedical Research
- Gene Therapy
- Ablation
- Oncology
- Cardiology
- Others
- Others
- By Mode
- In-Vitro/Clinical
- In-Vivo
- By End user
- Biopharmaceutical Companies
- Hospitals
- Research & Academic
- Institutes
- Others
- By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Bio-Rad Laboratories, Inc
- Thermo Fisher Scientific Inc.
- BTX ( a division of Harvard Bioscience)
- Celetrix, LLC.
- Gamma Biosciences
- Merck KgaA
- Eppendorf SE
- MaxCyte, Inc.
- BEX CO.,LTD.
- Lonza
- Altogen Biosystems
- Ala Scientific Instruments, Inc.
- BioEra Life Sciences Pvt. Ltd.
- Ichor Medical Systems
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Mode
- Market Snapshot, By End User
- Market Snapshot, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Overview -Application of Electroporation in various treatments
- Market Trends
- Key Highlights
- Regulatory Scenario
- PEST Analysis
- Porter's Analysis
- Technological Advancements
4. Global Electroporation Instruments Market, By Product Type, 2026-2033 (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Accessories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Electrodes
- Cuvettes
- Chambers
- Kits
- Others
5. Global Electroporation Instruments Market, By Application, 2026-2033 (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Protein Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Biomedical Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ablation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Oncology
- Cardiology
- Others
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Electroporation Instruments Market, By End User, 2026-2033 (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- In-vitro/clinical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- In-vivo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Electroporation Instruments Market, By End User, 2026-2033 (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Research & Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Electroporation Instruments Market By Region, 2026-2033 (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Regions, 2021-2033, (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Company Profiles
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BTX ( a division of Harvard Bioscience)
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Celetrix, LLC.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Gamma Biosciences
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck KgaA
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Eppendorf SE
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- MaxCyte, Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BEX CO.,LTD.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lonza
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Altogen Biosystems
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ala Scientific Instruments, Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BioEra Life Sciences Pvt. Ltd.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ichor Medical Systems
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
10. Section
- Research Methodology
- About Us and Services
